Clinical Trials on Hospital-acquired Pneumonia in Argentina

Total 185 results

Hospital General de Niños Pedro de Elizalde

Withdrawn

Corticosteroids in Community-acquired Pneumonia

Community-acquired Pneumonia

Argentina
Hospital General de Niños Pedro de Elizalde

Completed

Bacterial Pneumonia Score (BPS) Guided Antibiotic Use in Children With Pneumonia and Pneumococcal Vaccine

Community Acquired Pneumonia

Argentina
Pfizer

Terminated

Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia

Pneumonia, Bacterial

Canada, United States, Argentina, Australia, Brazil, Chile, Colombia, Croatia, France, Hungary, Korea, Republic of, Latvia, Russian Federation, Taiwan
Hospital Italiano de Buenos Aires

Completed

Causes of Nonattendance at Scheduled Outpatient Appointments (AU2)

Appointments and Schedules | Outpatient Clinics, Hospital

Argentina
Hospital Privado del Sur

Terminated

Efects of Noninvasive Mechanical Ventilation and Conventional Mechanical Ventilation in Patients With Severe Comunity Pneumonia (NIMV AND SCAP)

Acute Hypoxemic Respiratory Failure | Community Acquired Pneumonia.

Argentina
Hospital Italiano de Buenos Aires

Completed

Factors Associated With Nonattendance at Scheduled Outpatient Appointments in a University General Hospital (AU1)

Appointments and Schedules | Outpatient Clinics, Hospital/Economics

Argentina
Pfizer
Biomedical Advanced Research and Development Authority; Innovative Medicines...

Completed

A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. (REVISIT)

Ventilator Associated Pneumonia | Complicated Intra-abdominal Infection | Hosptial Acquired Pneumonia

Spain, China, Korea, Republic of, Philippines, United States, Romania, Taiwan, Italy, Malaysia, Mexico, India, Israel, Turkey, Greece, Thailand, Czechia, Croatia, Argentina, Russian Federation, Bulgaria, Ukraine
Rempex (a wholly owned subsidiary of Melinta Therapeutics...
Department of Health and Human Services

Completed

Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults

Bacteremia | Acute Pyelonephritis | Ventilator-associated Bacterial Pneumonia | Urinary Tract Infection Complicated | Hospital Acquired Bacterial Pneumonia | Abdominal Infection

Italy, United States, Colombia, Greece, Israel, Brazil, Argentina, United Kingdom
Hospital Italiano de Buenos Aires

Unknown

Non Attendance at Scheduled Appointments as a Marker of Mortality and Hospital Admission

Mortality | Hospitalization | Emergency Department | Appointments and Schedules | Outpatient Clinics, Hospital/Economics

Argentina
Forest Laboratories
AstraZeneca

Completed

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)

Infections | Community Acquired Pneumonia

Spain, United States, Argentina, Bulgaria, Georgia, Greece, Hungary, Poland, Ukraine
Hospital General de Niños Pedro de Elizalde

Completed

Bacterial Pneumonia Score (BPS) Guided Antibiotic Use in Children With Community Acquired Pneumonia

Pneumonia

Argentina
Laboratorios Roemmers S.A.I.C.F.

Unknown

Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)

COVID-19

Argentina
Universidad Nacional de Rosario

Terminated

Futility of Exhaled Breath Condensate pH Measurements in Ventilated Patients in Intensive Care Unit (ICU)

Death | Ventilator Associated Pneumonia

Argentina
Centro de Educación Medica e Investigaciones Clínicas...

Completed

Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia

Covid19 Pneumonia

Argentina
Sanatorio Finochietto

Completed

Tocilizumab in Covid-19 Penumonia in Buenos Aires City

COVID-19 Pneumonia | Tocilizumab

Argentina
Ministry of Public Health, Argentina

Completed

Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC) (IVERNEX-TUC)

Covid19

Argentina
Biotest

Recruiting

Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) (ESsCAPE)

Community-acquired Pneumonia

Australia, Spain, Israel, France, Brazil, United Kingdom, United States, Germany, Philippines, Belgium, Romania, Czechia, Hungary, Austria, Argentina, South Africa, New Zealand
Melinta Therapeutics, Inc.

Completed

Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia (DEFINE-CABP)

Community Acquired Bacterial Pneumonia

United States, Argentina, Bulgaria, Colombia, Dominican Republic, Georgia, Germany, Hungary, Latvia, Peru, Poland, Romania, Russian Federation, Serbia, Slovenia, South Africa, Spain, Ukraine
Nabriva Therapeutics AG

Completed

Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia (LEAP)

Community Acquired Pneumonia

United States, Argentina, Bosnia and Herzegovina, Brazil, Bulgaria, Georgia, Hungary, Latvia, Netherlands, Peru, Philippines, Poland, Romania, Russian Federation, Serbia, South Africa, Thailand, Ukraine
Melinta Therapeutics, Inc.

Completed

Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia (SOLITAIRE-ORAL)

Community-acquired Bacterial Pneumonia

Spain, United States, Hungary, Canada, Estonia, Russian Federation, Argentina, Bulgaria, Czech Republic, Dominican Republic, Ecuador, Germany, Latvia, Poland, Puerto Rico, Romania, South Africa
Instituto de Cardiología de Corrientes

Completed

Ivermectin to Prevent Hospitalizations in COVID-19 (IVERCORCOVID19)

Covid19

Argentina
Janssen Research & Development, LLC

Terminated

A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia

Pneumonia, Bacterial | Pneumonia, Ventilator-Associated | Nosocomial Infection | Community-Acquired Infections

Poland, Ukraine, United States, Argentina, Colombia, Brazil, Panama, Lithuania, Mexico, Latvia
Nabriva Therapeutics AG

Completed

Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia (LEAP2)

Community Acquired Pneumonia

United States, Argentina, Brazil, Bulgaria, Chile, Georgia, Hungary, Korea, Republic of, Latvia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Serbia, South Africa, Spain, Taiwan, Ukraine
Eurnekian Public Hospital

Completed

USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19 (IVERCAR)

Covid19

Argentina
Fernando Saldarini
Hospital de Infecciosas Francisco Javier Muniz; Universidad Nacional de la... and other collaborators

Completed

COVID-19 Sequelae: Treatment and Monitoring. A Dietary Supplement Based on Sea Urchin Eggs With Echinochroma A

Long COVID

Argentina
Asociacion Latinoamericana de Torax

Completed

COVID19 Hospitilized in Clinica Pasteur of Neuquen (Argentina) (COVIDPas)

COVID-19

Argentina
Ministry of Public Health, Argentina

Completed

Ivermectin Reproposing for Mild Stage COVID-19 Outpatients (IVER-Leve)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Argentina
Hospital General de Niños Pedro de Elizalde

Completed

Pediatric Virtual Visits as a Strategy for Access to Care During the COVID-19 Pandemic in a Pediatric Hospital

Telehealth

Argentina
Hospital Italiano de Buenos Aires
National Agency for Scientific and Technological Promotion, Argentina

Unknown

Liver Transplantation and Coronavirus Disease 2019 (COVID-19)

Covid19 | Liver Transplant

Argentina
Maria de los Angeles Peral de Bruno

Completed

Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan (Ivercar-Tuc)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Argentina
Estudios Clínicos Latino América
Population Health Research Institute

Completed

The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients. (COLCOVID)

COVID-19

Argentina
Melinta Therapeutics, Inc.

Completed

Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia (SOLITAIRE-IV)

Community-acquired Bacterial Pneumonia

Spain, United States, Philippines, Taiwan, Canada, Germany, Poland, Russian Federation, Argentina, Bulgaria, South Africa, Slovenia, Serbia, Colombia, Hungary, Netherlands, Slovakia, Ukraine, Peru, Latvia, Guatemala, Romania, Chile, G... and more
Hospital Italiano de Buenos Aires
Ministerio de Salud de Ciudad Autónoma de Buenos Aires

Completed

Safety of the Sputnik V Vaccine in Health Personnel of Private Effectors of the City of Buenos Aires, Argentina (COVID-19)

COVID-19

Argentina
Administracion Nacional de Laboratorios e Institutos...

Recruiting

Safety and Effectiveness of an Immunobiological Drug in CoViD-19 (INPB001)

Covid19 | COVID-19 Pneumonia | COVID-19 Respiratory Infection

Argentina
Fundacion Infant

Completed

Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection

Covid19 | Pregnancy Related | Neonatal Infection

Argentina
Hospital de Clinicas José de San Martín
SILVATEAM

Terminated

Tannin Specific Natural Extract for COVID-19 Infection (TanCOVID)

COVID-19 | Coronavirus Infection | SARS-CoV 2

Argentina
Hospital Italiano de Buenos Aires

Recruiting

Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19

Tocilizumab | Severe COVID 19 Pneumonia

Argentina
Eurnekian Public Hospital

Completed

Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19 (IDEA)

Severe Acute Respiratory Syndrome | Ventilation Pneumonitis

Argentina
Estudios Clínicos Latino América
Amarin Pharma Inc.

Completed

PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention Trial (PREPARE-IT)

COVID19

Argentina
Tiva Group

Unknown

Use of the Nasal Cannula During COVID-19

COVID 19

Argentina
Austral University, Argentina

Unknown

Liver Injury in Patients With COVID-19

Liver Injury

Argentina
Ariel Dogliotti
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno

Unknown

Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease (CARR-COV-02)

Covid19

Argentina
Hospital Italiano de Buenos Aires
University of Buenos Aires; Ministerio de Salud de Ciudad Autónoma de Buenos...

Completed

Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients

Renal Dialysis | Coronavirus Disease 2019 Vaccines

Argentina
Hospital Italiano de Buenos Aires

Completed

Immunity Against COVID-19 Vaccine in Healthcare Workers in Argentine

Healthcare Workers | Vaccine | Coronavirus 2019

Argentina
Hospital Nacional Profesor Alejandro Posadas

Completed

HYPONATREMIA IN COVID-19 PATIENTS

Covid19 | Corona Virus Infection | Hyponatremia

Argentina
Sanatorio Anchorena San Martin

Completed

Characteristics of Weaning From Mechanical Ventilation in COVID-19 (CovWean)

COVID-19 | Respiration, Artificial

Argentina
Arturo Jauretche National University
University of Buenos Aires; Hospital El Cruce; Universidad Nacional de La Plata; National University of Cuyo

Recruiting

Clinical and Biological Characterization of Post COVID-19 Syndrome

Long COVID

Argentina
Ministerio de Salud de Ciudad Autónoma de Buenos...

Completed

Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes

COVID-19 Vaccines

Argentina
Ministerio de Salud de Ciudad Autónoma de Buenos...

Completed

SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES

COVID-19

Argentina
Laboratorio Pablo Cassará S.R.L.
National Council of Scientific and Technical Research, Argentina; Universidad...

Completed

ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

COVID-19 Vaccine

Argentina

Clinical Trials on Hospital-acquired Pneumonia in Argentina

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations